Cell type-dependent control of NF-Y activity by TGF-β

被引:26
作者
Alabert, C. [1 ]
Rogers, L. [1 ]
Kahn, L. [1 ]
Niellez, S. [1 ]
Fafet, P. [1 ]
Cerulis, S. [1 ]
Blanchard, J. M. [1 ]
Hipskind, R. A. [1 ]
Vignais, M. -L. [1 ]
机构
[1] CNRS, Inst Mol Genet, UMR5535, IFR122, F-34293 Montpellier 5, France
关键词
TGF-beta; NF-Y; MAPK;
D O I
10.1038/sj.onc.1209385
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Transforming growth factor b (TGF-beta) is a pluripotent cytokine that regulates cell growth and differentiation in a cell type-dependent fashion. TGF-beta exerts its effects through the activation of several signaling pathways. One involves membrane proximal events that lead to nuclear translocation of members of the Smad family of transcriptional regulators. TGF-beta can also activate MAPK cascades. Here, we show that TGF-beta induces nuclear translocation of the NF-YA subunit of the transcription factor NF-Y by a process that requires activation of the ERK cascade. This results in increased binding of endogenous NF-Y to chromatin and TGF-beta-dependent transcriptional regulation of the NF-Y target gene cyclin A2. Interestingly, the kinetics of NF-YA relocalization differs between epithelial cells and fibroblasts. NIH3T3 fibroblasts show an elevated basal level of phosphorylated p38 and delayed nuclear accumulation of NF-YA after TGF-beta treatment. In contrast, MDCK cells show low basal p38 activation, higher basal ERK phosphorylation and more rapid localization of NF-YA after induction. Thus, NF-Y activation by TGF-beta 1 involves ERK1/2 and potentially an interplay between MAPK pathways, thereby opening the possibility for finely tuned transcriptional regulation.
引用
收藏
页码:3387 / 3396
页数:10
相关论文
共 51 条
[1]
Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism [J].
Adachi, M ;
Fukuda, M ;
Nishida, E .
JOURNAL OF CELL BIOLOGY, 2000, 148 (05) :849-856
[2]
PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO [J].
ALESSI, DR ;
CUENDA, A ;
COHEN, P ;
DUDLEY, DT ;
SALTIEL, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27489-27494
[3]
Smads as transcriptional co-modulators [J].
Attisano, L ;
Wrana, JL .
CURRENT OPINION IN CELL BIOLOGY, 2000, 12 (02) :235-243
[4]
BARLAT I, 1995, ONCOGENE, V11, P1309
[5]
BARLAT I, 1993, CELL GROWTH DIFFER, V4, P105
[6]
Bhattacharya A, 2003, CANCER RES, V63, P8167
[7]
The cyclin B2 promoter depends on NF-Y, a trimer whose CCAAT-binding activity is cell-cycle regulated [J].
Bolognese, F ;
Wasner, M ;
Lange-zu Dohna, C ;
Gurtner, A ;
Ronchi, A ;
Muller, H ;
Manni, I ;
Mossner, J ;
Piaggio, G ;
Mantovani, R ;
Engeland, K .
ONCOGENE, 1999, 18 (10) :1845-1853
[8]
Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase [J].
Bulavin, DV ;
Higashimoto, Y ;
Popoff, IJ ;
Gaarde, WA ;
Basrur, V ;
Potapova, O ;
Appella, E ;
Fornace, AJ .
NATURE, 2001, 411 (6833) :102-107
[9]
Feedback control of the protein kinase TAK1 by SAPK2a/p38α [J].
Cheung, PCF ;
Campbell, DG ;
Nebreda, AR ;
Cohen, P .
EMBO JOURNAL, 2003, 22 (21) :5793-5805
[10]
The transcriptional activity of the CCAAT-binding factor CBF is mediated by two distinct activation domains, one in the CBF-B subunit and the other in the CBF-C subunit [J].
Coustry, F ;
Maity, SN ;
Sinha, S ;
deCrombrugghe, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) :14485-14491